+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID02939573

Randomized Multicenter Trial Comparing Colchicine, Dapsone, and Azathioprine for Treatment of Isolated Skin Vasculitis

Led by University of Pennsylvania · Updated on 2026-08-20

90

Participants Needed

16

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multi-center randomized trial to compare the effectiveness of three standard treatments for patients with isolated skin vasculitis. This study focuses on adults with primary skin vasculitis conditions such as isolated cutaneous small vessel or medium-sized vessel vasculitis, cutaneous polyarteritis nodosa, and IgA vasculitis without significant kidney involvement. The goal is to evaluate how well these treatments control the skin symptoms over time. Participants are initially assigned randomly to one of three medications colchicine 0.6 mg twice daily, dapsone 150 mg daily, or azathioprine 2 mg per kg daily for six months. If the initial treatment is stopped due to lack of response, flare, or side effects within this period or up to 12 months, participants are then re-randomized to one of the two remaining drugs for another six months. This sequential approach allows researchers to assess responses across two treatment stages. During the study, participants will have regular assessments including physician and patient evaluations, quality of life questionnaires, and skin condition scores at scheduled intervals up to 12 months. The main measure is response to therapy at six months across both treatment stages. Safety and side effects will be monitored, and the total study duration for each participant may extend to one year, allowing detailed comparison of these treatments effects on skin vasculitis.

CONDITIONS

Brief Title

A Randomized Multicenter Study for Isolated Skin Vasculitis

Research Team

C

Carol McAlear, MA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here